Childhood pneumonia in developing countries

The Lancet Respiratory Medicine

Volumn 1, Issue 7, 2013, Pages 574-584

  Izadnegahdar, Rasa ^a   Cohen, Adam L ^b   Klugman, Keith P ^c,d   Qazi, Shamim A ^e  

^a BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c EMORY UNIVERSITY   (United States)

^d UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^e Child and Adolescent Health WHO ^*  (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMPICILLIN; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CEFTRIAXONE; COTRIMOXAZOLE; GENTAMICIN; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; PENICILLIN DERIVATIVE; PNEUMOCOCCUS VACCINE; ANTIINFECTIVE AGENT; RESPIRATORY TRACT AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; CHILDHOOD DISEASE; DEVELOPING COUNTRY; HAEMOPHILUS INFECTION; HAEMOPHILUS INFLUENZAE TYPE B; HEALTH CARE MANAGEMENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MORTALITY; NONHUMAN; NUTRITIONAL SUPPORT; OXYGEN THERAPY; PNEUMONIA; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; REVIEW; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE; THORAX RADIOGRAPHY; DRUG COMBINATION; INFANT; NEWBORN; PNEUMONIA, BACTERIAL; PNEUMONIA, VIRAL; PRACTICE GUIDELINE; PRESCHOOL CHILD; STATISTICS AND NUMERICAL DATA;

ANTI-BACTERIAL AGENTS; CHILD, PRESCHOOL; DEVELOPING COUNTRIES; DRUG THERAPY, COMBINATION; HUMANS; INFANT; INFANT, NEWBORN; PNEUMONIA, BACTERIAL; PNEUMONIA, VIRAL; PRACTICE GUIDELINES AS TOPIC; RESPIRATORY SYSTEM AGENTS;

EID: 84883456713     PISSN: 22132600     EISSN: None     Source Type: Journal    
DOI: 10.1016/S2213-2600(13)70075-4     Document Type: Review

References (88)

1. United Nations Inter-Agency Group for Child Mortality Estimation. Levels and trends in child mortality report 2012. United Nations Children's Fund.
2. Williams BG, Guows E, Boschi-Pinto C, Bryce J, Dye C Estimates of world-wide distribution of child deaths from acute respiratory infections. Lancet Infect Dis 2002, 2:25-32.
3. Leowski J Mortality from acute respiratory infections in children under 5 years of age: global estimates. World Health Stat Q 1986, 39:138-144.
4. Garenne M, Ronsmans C, Campbell H The magnitude of mortality from acute respiratory infections in children under 5 years in developing countries. World Health Stat Q 1992, 45:180-191.
5. Progress Report 2012: committing to child survival: a promise renewed 2012, UNICEF, United Nations Children's Fund, Division on Policy and Strategy.
6. Black RE, Cousens S, Johnson HL, et al. Global, regional, and national causes of child mortality in 2008: a systematic analysis. Lancet 2010, 375:1969-1987.
7. Liu L, Johnson HL, Cousens S, et al. Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000. Lancet 2012, 379:2151-2161.
8. Bryce J, Boschi-Pinto C, Shibuya K, Black RE WHO estimates of the causes of death in children. Lancet 2005, 365:1147-1152.
9. Rudan I, Boschi-Pinto C, Biloglav Z, Mulholland K, Campbell H Epidemiology and etiology of pneumonia. Bull World Health Organ 2008, 36:408-416.
10. Rudan I, Tomaskovic L, Boschi-Pinto C, Campbell H Global estimate of the incidence of clinical pneumonia among children under 5 years of age. Bull World Health Organ 2004, 82:895-903.
11. Lozano R, Naghavi N, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012, 380:2095-2128.
12. Liu L, Perin J, Fisher-Walker C, Black RE Interim estimates of global under-five diarrhea and pneumonia deaths in 2011. Published Nov 30, 2011 (accessed Dec 1, 2012.). http://cherg.org/publications/Interim-2011-Diarrhea-and-Pneumonia-Deaths-30Nov2012.pdf.
13. Rudan I, Chan KY, Zhang JS, et al. Causes of death in children younger than 5 years in China in 2008. Lancet 2010, 375:1083-1089.
14. Cohen AL, Hyde TB, Verani J, Watkins M Integrating pneumonia prevention and treatment interventions with immunization services in resource-poor countries. Bull World Health Organ 2012, 90:289-294.
15. VIMS report: global vaccine introduction 2012, International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health International Vaccine Access Center, Baltimore.
16. Selwyn BJ The epidemiology of acute respiratory tract infection in young children: comparison of findings from several developing countries. Rev Infect Dis 1990, 12:S870-S888.
17. Watt JP, Wolfson LJ, O'Brien KL, et al. Burden of disease caused by Haemophilus influenzae type b in children younger than 5 years: global estimates. Lancet 2009, 374:903-911.
18. Watt JP, Wolfson LJ, O'Brien KL, et al. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet 2009, 374:893-902.
19. Cutts FT, Zaman SMA, Enwere G, et al. Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial. Lancet 2005, 365:1139-1146.
20. Calder D, Qazi S Evidence behind the WHO guidelines: hospital care for children: what is the aetiology of pneumonia in HIV-infected children in developing countries?. J Trop Pediatr 2009, 55:219-224.
21. Levine OS, Knoll MD, Jones A, Walker DG, Risko N, Gilani Z Global status of Haemophilus influenzae type b and pneumococcal conjugate vaccines: evidence, policies, and introductions. Curr Opin Infect Dis 2010, 23:236-241.
22. Levine OS, O'Brien KL, Deloria-Knoll M, et al. The pneumonia etiology research for child health project: a 21st century childhood pneumonia etiology study. Clin Infect Dis 2012, 54:S93-101.
23. Neuman MI, Monuteaux MC, Scully KJ, Bachur RG Prediction of pneumonia in a pediatric emergency department. Pediatrics 2011, 128:246-253.
24. Wingerter SL, Bachur RG, Monuteaux MC, Neuman MI Application of the World Health Organization criteria to predict radiographic pneumonia in a US-based pediatric emergency department. Pediatr Infect Dis J 2012, 31:561-564.
25. Shah S, Matthews B, Neuman MI, Bachur R Detection of occult pneumonia in a pediatric emergency department. Pediatr Emerg Care 2010, 26:615-621.
26. Bachur R, Perry H, Harper MB Occult pneumonias: empiric chest radiographs in febrile children with leukocytosis. Ann Emerg Med 1999, 33:166-173.
27. Cherian T, Mulholland EK, Carlin JB, et al. Standardized interpretation of pediatric chest radiographs for the diagnosis of pneumonia in epidemiological studies. Bull World Health Organ 2005, 83:353-359. for the TWRW Group.
28. Shimol BS, Dagan R, Givon-Lavi N, et al. Evaluation of the World Health Organization criteria for chest radiographs for pneumonia diagnosis in children. Eur J Pediatr 2012, 171:369-374.
29. O'Grady KF, Torzillo PJ, Ruben AR, et al. Identification of radiological alveolar pneumonia in children with high rates of hospitalized respiratory infections: comparison of WHO-defined and pediatric pulmonologist diagnosis in the clinical context. Pediatr Pulmonol 2012, 47:386-392.
30. Esposito S, Principi N Unsolved problems in the approach to pediatric community acquired pneumonia. Curr Opin Infect Dis 2012, 25:286-291.
31. Mehr S, Wood N Streptococcus pneumoniae - a review of carriage, infection, serotype replacement and vaccination. Pediatr Respir Rev 2012, 13:258-264.
32. Shah SS, Dugan MH, Bell LM Blood cultures in the emergency department evaluation of childhood pneumonia. Pediatr Infect Dis 2011, 20:475-479.
33. Resti M, Moriondo M, Cortimiglia M, et al. Community-acquired bacteremic pneumococcal pneumonia in children: diagnosis and serotyping by polymerase chain reaction using blood samples. Clin Infect Dis 2010, 51:1042-1049.
34. Ramirez M, Melo-Cristino J Expanding the diagnosis of pediatric bacteremic pneumococcal pneumonia from blood cultures to molecular method: advantages and caveats. Clin Infect Dis 2010, 51:1050-1052.
35. Charkaluk ML, Kalach N, Mvogo H Assessment of rapid urinary antigen detection by an immunochromotographic test for diagnosis of pneumococcal infection in children. Diagn Micriobiol Infect Dis 2006, 55:89-94.
36. Pride MW, Huijts SM, Wu K, et al. Validation of an immunodiagnostic assay for detection of 13 Streptococcus pneumoniae serotype-specific polysaccharides in human urine. Clin Vacc Immunol 2012, 19:1131-1141.
37. Klugman KP, Madhi SA, Albrich WC Novel approaches to the identification of Streptococcus pneumoniae as the cause of community-acquired pneumonia. Clin Infect Dis 2008, 47:S202-S206.
38. Esposito S, Tagaliabue C, Picciolli I, et al. Procalcitonin measurements for guiding antibiotic treatment in pediatric pneumonia. Respir Med 2011, 105:1939-1945.
39. Albrich WC, Madhi SA, Adrian PV, et al. Use of a rapid test of pneumococcal colonization density to diagnose pneumococcal pneumonia. Clin Infect Dis 2012, 54:601-609.
40. Vu HT, Yoshida LM, Suzuki M, et al. Association between nasopharyngeal load of Streptococcus pneumoniae, viral coinfection, and radiologically confirmed pneumonia in Vietnamese children. Pediatr Infect Dis J 2011, 30:11-18.
41. Pavia AT Viral infections of the lower respiratory tract: old viruses, new viruses, and the role of diagnosis. Clin Infect Dis 2011, 52:S284-S289.
42. Lee JH, Chun JK, Kim DS, Park Y, Choi JR, Kim HS Identification of adenovirus, influenza virus, parainfluenza virus and respiratory syncytial virus by two kinds of multiplex polymerase chain reaction (PCR) and a shell vial culture in pediatric patients with viral pneumonia. Yonsei Med J 2010, 51:761-767.
43. O'Callaghan-Gordo C, Bassat Q, Morais L, et al. Etiology and epidemiology of viral pneumonia among hospitalized children in rural Mozambique. Pediatr Infect Dis 2010, 30:39-44.
44. Tsolia MN, Psarras S, Bossios A Etiology of community-acquired pneumonia in hospitalized school-age children: evidence for high prevalence of viral infections. Clin Infect Dis 2004, 39:681-686.
45. Nichols WG, Peck Campbell AJ, Boeck M Respiratory viruses other than influenza virus: impact and therapeutic advances. Clin Microbiol Rev 2008, 21:274-290.
46. Clinical management of acute respiratory infections in children: a WHO memorandum. Bull World Health Organ 1981, 59:707-716. WHO.
47. The management of acute respiratory infections in children. Practical guidelines for outpatient care 1995, WHO, World Health Organization, Geneva.
48. UNICEF. Integrated management of childhood illness. Assess and classify the sick child age 2 months up to 5 years 1997, WHO, WHO, Geneva.
49. Sazawal S, Black RE Effect of pneumonia case management on mortality in neonates, infants, and preschool children: a meta-analysis of community-based trials. Lancet Infect Dis 2003, 3:547-556.
50. Technical updates of the guidelines on the Integrated Management of Childhood Illness (IMCI): evidence and recommendations for further adaptations 2005, WHO, WHO, Department of Child and Adolescent Health and Development, Geneva.
51. Pocket book of hospital care for children: guidelines for the management of common illnesses with limited resources 2013, WHO, World Health Organization, Geneva. Second edition.
52. Soofi S, Ahmed S, Fox MP, et al. Effectiveness of community case management of severe pneumonia with oral amoxicillin in children aged 2-59 months in Matiar district, rural Pakistan: a cluster-randomised controlled trial. Lancet 2012, 379:729-737.
53. Bari A, Sadruddin S, Khan A, et al. Community case management of severe pneumonia with oral amoxicillin in children aged 2-59 months in Haripur district, Pakistan: a cluster randomised trial. Lancet 2011, 378:1796-1803.
54. Graham SM, English M, Hazir T, Enarson P, Duke T Challenges to improving case management of childhood pneumonia at health facilities in resource-limited settings. Bull World Health Organ 2008, 86:349-355.
55. Recommendations for management of common childhood conditions: evidence for technical update of pocket book recommendations: newborn conditions, dysentery, pneumonia, oxygen use and delivery, common causes of fever, severe acute malnutrition and supportive care 2012, WHO, World Health Organization, Department of Child and Adolescent Health and Development, Geneva.
56. Straus WL, Qazi SA, Kundi Z, Nomani NK, Schwartz B Antimicrobial resistance and clinical effectiveness of co-trimoxazole versus amoxycillin for pneumonia among children in Pakistan: randomised controlled trial. Lancet 1998, 352:270-274.
57. Leiberman A, Leibovitz E, Piglansky L, et al. Bacteriologic and clinical efficacy of trimethoprim-sulfamethoxazole for treatment of acute otitis media. Pediatr Infect Dis Jl 2001, 20:260-264.
58. Crowther-Gibson P, Cohen C, Klugman KP, Gouveia L, von Gottberg A Risk factors for multi-drug resistant invasive pneumococcal disease in South Africa, a setting with high HIV prevalence in the prevaccine era from 2003-2008. Antimicrob Agents Chemother 2012, 56:5088-5095.
59. Hazir T, Nisar YB, Abbasi S, et al. Comparison of oral amoxicillin with placebo for the treatment of world health organization-defined nonsevere pneumonia in children aged 2-59 months: a multicenter, double-blind, randomized, placebo-controlled trial in Pakistan. Clin Infect Dis 2011, 52:293-300.
60. Hazir T, Qazi SA, Nisar YB, et al. Can WHO therapy failure criteria for non-severe pneumonia be improved in children aged 2-59 months?. Int J Tuberc Lung Dis 2006, 10:924-931.
61. Hazir T, Fox LM, Nisar YB, et al. Ambulatory short-course high-dose oral amoxicillin for treatment of severe pneumonia in children: a randomised equivalency trial. Lancet 2008, 371:49-56.
62. Victora CG, Wagstaff A, Schellenberg JA, et al. Applying an equity lens to child health and mortality: more of the same is not enough. Lancet 2003, 362:233-241.
63. Mulholland EK, Smith L, Carneiro L, Becherc H, Lehmannd D Equity and child-survival strategies. Bull World Health Organ 2008, 86:399-407.
64. Priority medicines for mothers and children 2011 2011, WHOrgan, World Health Organization, Geneva.
65. Byington CL Molecular epidemiology of pediatric pneumococcal empyema from 2001 to 2007 in Utah. J Clin Microbiol 2010, 48:520-525.
66. Grijalva CG, Zhu Y, Nuorti JP, Griffin MR Emergence of parapneumonic empyema in the USA. Thorax 2011, 66:663-668.
67. Yu J, Salamon D, Marcon M, Nahm MH Pneumococcal serotypes causing pneumonia with pleural effusion in pediatric patients. J Clin Microbiol 2011, 49:534-538.
68. Saha SK, Naheed A, El Arifeen S, et al. Surveillance for invasive Streptococcus pneumoniae disease among hospitalized children in Bangladesh: antimicrobial susceptibility and serotype distribution. Clin Infect Dis 2009, 48:S75-S81.
69. Palmu AA, Jokinen J, Borys D, et al. Effectiveness of the ten-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) against invasive pneumococcal disease: a cluster randomised trial. Lancet 2013, 381:214-222.
70. Grijalva CG, Nuorti JP, Arbogast PG, Martin SW, Edwards KM, Griffin MR Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis. Lancet 2007, 369:1179-1186.
71. Whitney CG, Farley MM, Hadler J, et al. Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States. N Engl J Med 2000, 343:1917-1924.
72. Dias R, Louro D, Canica M Antimicrobial susceptibility of invasive Streptococcus pneumoniae isolates in Portugal over an 11-year period. Antimicrob Agents Chemother 2006, 50:2098-2105.
73. Anderson DI The biological cost of mutational antibiotic resistance: any practical conclusions?. Curr Opin Microbiol 2006, 9:461-465.
74. Silva RF, Mendonça SC, Carvalho LM, et al. Pervasive sign epistasis between conjugative plasmids and drug-resistance chromosomal mutations. PLoS Gen 2011, 7:e1002181.
75. Levin Br Models for the spread of resistant pathogens. Netherlands J Med 2002, 62:58-66.
76. Fireman B, Black SB, Shinefield HR, Lee J, Lewis E, Ray P Impact of the pneumococcal conjugate vaccine on otitis media. Pediatr Infect Dis J 2003, 22:10-16.
77. Madhi SA, Schoub B, Klugman KP Interaction between influenza virus and Streptococcus pneumoniae in severe pneumonia. Expert Rev Respir Med 2008, 2:663-672.
78. Steinhoff MC, Omer SB, Roy E, et al. Neonatal outcomes after influenza immunization during pregnancy: a randomized controlled trial. CMAJ 2012, 184:645-653.
79. Thurman KA, Walter ND, Schwartz SB, et al. Comparison of laboratory diagnostic procedures for detection of Mycoplasma pneumoniae in community outbreaks. Clin Infect Dis 2009, 48:1244-1249.
80. Kallander K, Nsungwa-Sabiiti J, Peterson S Symptoms overlap for malaria and pneumonia-policy implications for home management strategies. Acta Trop 2004, 90:211-214.
81. Waitumbi JN, Kuypers J, Anyona SB, et al. Outpatient upper respiratory tract viral infections in children with malaria symptoms in Western Kenya. Am J Tropl Med Hyg 2010, 83:1010-1013.
82. Reed C, Madhi SA, Klugman KP, et al. Development of the respiratory index of severity in children (RISC) score among young children with respiratory infections in South Africa. PLoS One 2012, 7:e27793.
83. Duke T, Wandi F, Jonathan M, et al. Improved oxygen systems for childhood pneumonia: a multihospital effectiveness study in Papua New Guinea. Lancet 2008, 372:1328-1333.
84. Enarson PM, Gie R, Enarson DA, Mwansambo C Development and implementation of a national programme for the management of severe and very severe pneumonia in children in Malawi. PLoS Med 2009, 6:e1000137.
85. Weber MW, Mulholland EK Pulse oximetry in developing countries. Lancet 1998, 351:1589.
86. Yakoob MY, Theodoratou E, Jabeen A, et al. Preventive zinc supplementation in developing countries: impact on mortality and morbidity due to diarrhea, pneumonia and malaria. BMC Public Health 2011, 11(suppl 3):S23.
87. Bhutta ZA, Soofi S, Cousens S, et al. Improvement of perinatal and newborn care in rural Pakistan through community-based strategies: a cluster-randomised effectiveness trial. Lancet 2011, 377:403-412.
88. Global action plan for prevention and control of pneumonia (GAPP) 2009, WHO, UNICEFUNICEF, World Health Organization and United Nations Children's Fund, Geneva, (accessed Dec 1, 2012). http://whqlibdoc.who.int/hq/2009/WHO_FCH_CAH_NCH_09.04_eng.pdf.